5 research outputs found

    Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso.

    No full text
    Traceability is an essential tool for haemovigilance and transfusion safety. In Burkina Faso, the implementation of haemovigilance has been achieved as part of a pilot project from 2005 to 2009. Our study aims to evaluate the traceability of blood transfusions and reporting of adverse reactions over the 6-year postpilot phase. A cross-sectional study including all blood units ordered between 2010 and 2015 has been conducted in public and private health care facilities supplied with blood products by the transfusion center of Bobo-Dioulasso. The complete traceability was possible for 83.5% of blood units delivered. Adverse reactions were reported in 107 cases representing 2.1/1,000 blood units per annum. Transfusions of wrong blood to wrong patient were reported in 13 cases. Our study shows that the haemovigilance system in Burkina Faso must be improved. Healthcare workers have to be sensitized on how traceability and haemovigilance could impact the quality of care provided to patients

    Implementation of Blood and Blood Product Regulation Training Workshop, South Africa

    No full text
    The training workshop on Implementation of Blood and Blood Product Regulation was organised and co-hosted by the Paul-Ehrlich -Institut Global Health Protection Program BloodTrain and the Africa Society for Blood Transfusion (AfSBT) from the 20th to the 22nd of August 2019. This was aimed at strengthening the capacity of African countries in developing and implementing regulatory systems for blood. Over thirty participants from countries across the African continent came together in Johannesburg, South Africa and shared knowledge and experiences among themselves and also with experts from the BloodTrain, Africa Society for Blood Transfusion (AfSBT), World Health Organization (WHO) and the New Partnership for Africa`s Development (NEPAD). The workshop addressed a wide range of topics ranging from standards in transfusion, clinical practice, regulatory framework for blood, WHO guidelines related to blood regulation, haemovigilance and regulatory oversight of associated Medical Devices In-vitro Diagnostics. In addition to the context and motivation of the workshop, this report summarises the key content covered throughout the workshop and recommendations for further improvement.Un atelier de formation portant sur la mise en oeuvre de la réglementation du sang et des produits sanguin s a été co-organisé par le programme de protection de la santé mondiale Paul-Ehrlich-Institut BloodTrain et la Société Africaine de Transfusion Sanguine (SATS) du 20 au 22 août 2019. Il visait à renforcer la capacité des pays africains à élaborer et à mettre en oeuvre des systèmes de réglementation pour le sang. Plus de trente participants de pays du continent africain se sont réunis à Johannesburg, en Afrique du Sud et ont partagé leurs connaissances et leurs expériences entre eux ainsi qu'avec des experts de BloodTrain, de la SATS, de l'Organisation Mondiale de la Santé (OMS) et du Nouveau partenariat pour le développement de l'Afrique (NEPAD). L'atelier a abordé un large éventail de sujets, allant des normes de transfusion, de la pratique clinique, du cadre réglementaire pour le sang, des directives de l'OMS relatives à la régulation du sang, à l'hémovigilance et à la surveillance réglementai re des diagnostics in vitro des dispositifs médicaux associés. En plus du contexte et de la motivation de l'atelier, ce rapport résume le contenu clé couvert tout au long de l'atelier et des recommandations pour de nouvelles améliorations
    corecore